Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v1-EN
Language French English
Date Updated 2017-12-22 2017-11-22
Drug Identification Number 02353261 02353261
Brand name GABAPENTIN GABAPENTIN
Common or Proper name GABAPENTIN CAP GABAPENTIN CAP
Company Name SANIS HEALTH INC SANIS HEALTH INC
Ingredients GABAPENTIN GABAPENTIN
Strength(s) 400MG 400MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 500 500
ATC code N03AX N03AX
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2017-11-29 2017-11-29
Actual start date 2017-11-22
Estimated end date 2017-12-29 2017-12-29
Actual end date 2017-12-21
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Delay in release of replenishment batch Delay in release of replenishment batch
Health Canada comments